Expert Dossiers
Jack Kruse Central Dogma: Light–Water–Magnetism Hierarchy Graded
The stack is a totalizing hierarchy: light and nnEMF first, water as medium, food second-order. Extract kernels; reject ranking absolutism as clinical policy.
The system is a totalizing hierarchy: light/nnEMF first, water as medium, food second-order, cold as effector. Extract kernels; treat light > food always as speculative dogma, not medical algorithm.
Narrative coherence is not external constraint. High story fit with low falsifiability is follower lock-in risk.
This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.
What hierarchy content appears in primary sources?
The About manifesto places artificial spectrum and grid-era EM environment at the start of mitochondrial disease stories and frames obesity as beginning in the eye. Queer Water casts coherent interfacial water as the quantum enzyme of life. Leptin Rx gates later understanding through EMF series. Cold thermogenesis amplifies thermogenic programs after leptin base.
Secondary triad summaries operationalize light, water, and magnetism as the controlling set, including device meetups that pair theory with hardware. Curriculum order is part of the dogma, not an accident of blogging chronology alone.
Why is the integrated model persuasive yet risky?
It unifies many diseases under one controllable story and re-explains failure without abandoning the model. Aligns with real lived experiences such as better sleep after morning light and satiety with protein breakfasts that then halo-validate unproven layers.
Epistemic risk rises when every miss is residual blue light or 5G rather than energy intake, medications, sleep apnea, or genetics. Non-falsifiable practical loops are incompatible with clinical decision algorithms that must update on disconfirming data.
| Module | Independent support |
|---|---|
| Morning light / night dark | High (circadian science) |
| Seafood omega-3 patterns | High–moderate |
| Acute cold / BAT effects | Moderate physiologic |
| Leptin biology (mainstream) | High; branded Rx rewiring low |
| Structured water therapy | Very low |
| nnEMF epidemic primacy | Speculative vs IARC caution |
| Light > food ranking rule | Speculative / D |
How should editorial and clinical readers respond?
Decompose the stack. Allow complementary circadian plus nutrition without ranking absolutism. Label totalizing models as worldview, not medical algorithm. Prefer shared hygiene practices across schools—morning light, sleep dark, fish, less snacking—over allegiance to hierarchy branding.
Ask what outcome would disprove light primacy. Compare competing hierarchies: energy-balance-first, sleep-first, drug-first care paths. Device dependency is not proof of theory. See primary hierarchy cues on the About page and Leptin Rx curriculum gates.
What anti-patterns should be rejected?
Publishing the hierarchy as settled physics of metabolism. Shaming calorie discussion as always propaganda. One-size dogma across pregnancy, illness, and elite athletes without modification. Treating Quantlet-style hardware as experimental confirmation of cosmic water law.
Modular extraction is the ethical editorial move: steal kernels that map to mainstream evidence; leave the ranking absolutism and non-falsifiable troubleshooting loops that punish dissent as insufficient light purity.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Editorial note: ranges and protocol bands cited here are literature and guideline context for shared decision-making with clinicians—not self-directed treatment schedules, home lab targets, or substitute care for emergencies or progressive organ disease.
Sources & citations
Frequently asked